Vietnam Veterans Liver Fluke Cancer Study Act

Hozzl · 2024-10-04T19:57:12Z

Explore the details of House Bill 4424 Vietnam Veterans Liver Fluke Cancer Study Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Armed Forces and National Security. Stay informed on legislative developments.

10/4/2024, 7:57 PM

Summary of Bill HR 4424

Bill 118 hr 4424, also known as the Vietnam Veterans Liver Fluke Cancer Study Act, is a piece of legislation introduced in the US Congress. The purpose of this bill is to authorize the Department of Veterans Affairs to conduct a study on the potential link between liver fluke parasites and bile duct cancer in Vietnam veterans.

The bill specifically focuses on veterans who served in the Vietnam War and were exposed to liver fluke parasites, which are known to cause bile duct cancer. The study aims to investigate the prevalence of this type of cancer among Vietnam veterans and determine if there is a direct correlation between exposure to liver fluke parasites and the development of bile duct cancer.

If passed, the bill would require the Department of Veterans Affairs to report its findings to Congress within a specified timeframe. This information would be crucial in helping to better understand and address the health concerns of Vietnam veterans who may have been affected by liver fluke parasites. Overall, the Vietnam Veterans Liver Fluke Cancer Study Act seeks to provide important insights into the potential health risks faced by Vietnam veterans and ensure that they receive the necessary support and care.

Congressional Summary of HR 4424

Vietnam Veterans Liver Fluke Cancer Study Act

This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study shall identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents.

The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry.

Additionally, the bill extends certain loan fee rates through November 29, 2031, under the VA's home loan program.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 4424

Bill HR 4424 is currently in the status of Introduced to Senate since September 18, 2024. Bill HR 4424 was introduced during Congress 118 and was introduced to the House on June 30, 2023. Bill HR 4424's most recent activity was Received in the Senate. as of September 18, 2024

Bipartisan Support of Bill HR 4424

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 4424

Primary Policy Focus

Armed Forces and National Security

Potential Impact Areas

- Asia

- Cancer

- Conflicts and wars

- Congressional oversight

- Government studies and investigations

- Health information and medical records

- Medical research

- Veterans' medical care

- Vietnam

Alternate Title(s) of Bill HR 4424

Vietnam Veterans Liver Fluke Cancer Study Act

To direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era, and for other purposes.